Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNexus Gene Lab (BGLC) Return on Assets (2019 - 2025)

BioNexus Gene Lab's Return on Assets history spans 7 years, with the latest figure at 0.35% for Q4 2025.

  • Quarterly results put Return on Assets at 0.35% for Q4 2025, down 21.0% from a year ago — trailing twelve months through Dec 2025 was 0.35% (down 21.0% YoY), and the annual figure for FY2025 was 0.3%, down 16.0%.
  • Return on Assets for Q4 2025 was 0.35% at BioNexus Gene Lab, down from 0.27% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.08% in Q4 2021 to a low of 0.35% in Q4 2025.
  • The 5-year median for Return on Assets is 0.07% (2023), against an average of 0.11%.
  • The sharpest move saw Return on Assets plummeted -108bps in 2021, then increased 24bps in 2024.
  • Year by year, Return on Assets stood at 0.08% in 2021, then tumbled by -153bps to 0.04% in 2022, then crashed by -431bps to 0.23% in 2023, then surged by 36bps to 0.14% in 2024, then crashed by -144bps to 0.35% in 2025.
  • According to Business Quant data, Return on Assets over the past three periods came in at 0.35%, 0.27%, and 0.31% for Q4 2025, Q3 2025, and Q2 2025 respectively.